 Immunological serological markers progression AIDS cohort HIV-infected drug users prospective follow-up evolution HIV infection cohort HIV-positive intravenous drug users IVDUs immunological serological variables predictive development AIDS stepwise multivariate analysis actuarial progression rate number powerful predictor progression AIDS independent predictive effects variable predictive power loss antibody antigen anergy HIV antigenaemia loss antibody transcriptase number cells loss antibody loss antibody level loss antibodies level data differ studies homosexual men different prognostic value predictive markers findings high risk progression clinical AIDS IVDUs selection patients prophylaxis therapy